B
bremelanotide
Productby AMAG Pharmaceuticals
Heard in 4 episodes across 2 shows since Jul 2026
A melanocortin receptor agonist marketed as Vyleesi and approved in the United States for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
Episodes
4
across 2 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of bremelanotide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Aug 25 | 0.03‰ | 2 |
| Sep 1 | 0.02‰ | 2 |
| Oct 16 | 0.03‰ | 3 |
Email alert
Email me when bremelanotide comes up on a podcast
One email a week at most, with the new episodes that mention bremelanotide. Free, no account needed, unsubscribe in one click.
Episodes
4 episodes featuring bremelanotide, newest first
- Oct 16, 2026
Sexual medicine exposes menopause care’s biggest blind spotsunPAUSED with Dr. Mary Claire HaverOct 16, 2026 - Sep 1, 2026
Testosterone enters the menopause conversationunPAUSED with Dr. Mary Claire HaverSep 1, 2026 - Aug 25, 2026
Menopause care still lags behind women’s lived experienceunPAUSED with Dr. Mary Claire HaverAug 25, 2026 - Jul 22, 2026
Andrew Huberman outlines the science of high-intensity training and peptidesThe Tim Ferriss ShowJul 22, 2026